Cash Flow Statement

Altimmune (ALT) EBIT Margin Growth (5y) (2015 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Altimmune 379.61 Mn 379.61 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -11.07 Mn
Sep 30, 2025 -41.66 Mn
Jun 30, 2025 -45.80 Mn
Mar 31, 2025 -43.60 Mn
Dec 31, 2024 -49.66 Mn
Sep 30, 2024 -49.36 Mn
Jun 30, 2024 -53.47 Mn
Mar 31, 2024 -53.58 Mn
Dec 31, 2023 -8.98 Mn
Sep 30, 2023 -607,248.00
Jun 30, 2023 -29.99 Mn
Mar 31, 2023 -10.34 Mn
Dec 31, 2022 -8.81 Mn
Sep 30, 2022 -123.69 Mn
Jun 30, 2022 -25.48 Mn
Mar 31, 2022 -5.94 Mn
Dec 31, 2021 -23,946.00
Sep 30, 2021 7.60 Mn
Jun 30, 2021 -1.79 Mn
Mar 31, 2021 -164,866.00
Dec 31, 2020 -39,056.00
Sep 30, 2020 -48,021.00
Jun 30, 2020 -22,095.00
Mar 31, 2020 -34,665.00
Dec 31, 2019 -60,524.00
Sep 30, 2019 -133,539.00
Jun 30, 2019 -18,640.00
Mar 31, 2019 -1,461.00
Dec 31, 2018 -91,769.00
Sep 30, 2018 -6,233.00
Jun 30, 2018 -19,039.00
Mar 31, 2018 -20,592.00
Dec 31, 2017 -68,806.00
Sep 30, 2017 -64,732.00
Jun 30, 2017 -10,895.00
Mar 31, 2017 -148,198.00
Dec 31, 2016 -47,511.00
Sep 30, 2016 -9.69 Mn
Jun 30, 2016 -22,478.00
Mar 31, 2016 -5,310.00
Dec 31, 2015 3,145.00
Sep 30, 2015 -8,960.00
Jun 30, 2015 -5,507.00